1121 related articles for article (PubMed ID: 9721799)
61. A prospective, randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: results at 1 year.
Mendez R; Gonwa T; Yang HC; Weinstein S; Jensik S; Steinberg S;
Transplantation; 2005 Aug; 80(3):303-9. PubMed ID: 16082323
[TBL] [Abstract][Full Text] [Related]
62. Simultaneous kidney-pancreas transplantation without antilymphocyte induction.
Reddy KS; Stratta RJ; Shokouh-Amiri H; Alloway R; Somerville T; Egidi MF; Gaber LW; Gaber AO
Transplantation; 2000 Jan; 69(1):49-54. PubMed ID: 10653379
[TBL] [Abstract][Full Text] [Related]
63. Use of tacrolimus and mycophenolate mofetil as induction and maintenance in simultaneous pancreas-kidney transplantation.
Ciancio G; Lo Monte A; Buscemi G; Miller J; Burke GW
Transpl Int; 2000; 13 Suppl 1():S191-4. PubMed ID: 11111994
[TBL] [Abstract][Full Text] [Related]
64. Rejection in single versus combined pancreas and kidney transplantation in pigs.
Gruessner RW; Nakhleh R; Tzardis P; Platt JL; Schechner R; Gruessner A; Tomadze G; Matas A; Najarian JS; Sutherland DE
Transplantation; 1993 Nov; 56(5):1053-62. PubMed ID: 8249099
[TBL] [Abstract][Full Text] [Related]
65. 2011 update on pancreas transplantation: comprehensive trend analysis of 25,000 cases followed up over the course of twenty-four years at the International Pancreas Transplant Registry (IPTR).
Gruessner AC
Rev Diabet Stud; 2011; 8(1):6-16. PubMed ID: 21720668
[TBL] [Abstract][Full Text] [Related]
66. The impact of mycophenolate mofetil versus azathioprine as adjunctive therapy to cyclosporine on the rates of renal allograft loss due to glomerular disease recurrence.
Pham PT; Pham PC
Nephrol Dial Transplant; 2012 Jul; 27(7):2965-71. PubMed ID: 22207327
[TBL] [Abstract][Full Text] [Related]
67. Conversion from tacrolimus-mycophenolate mofetil to tacrolimus-mTOR immunosuppression after kidney-pancreas transplantation reduces the incidence of both BK and CMV viremia.
Knight RJ; Graviss EA; Nguyen DT; Kuten SA; Patel SJ; Gaber L; Gaber AO
Clin Transplant; 2018 Jun; 32(6):e13265. PubMed ID: 29676018
[TBL] [Abstract][Full Text] [Related]
68. The surgical risk of pancreas transplantation in the cyclosporine era: an overview.
Gruessner RW; Sutherland DE; Troppmann C; Benedetti E; Hakim N; Dunn DL; Gruessner AC
J Am Coll Surg; 1997 Aug; 185(2):128-44. PubMed ID: 9249080
[TBL] [Abstract][Full Text] [Related]
69. Efficacy and safety of tacrolimus compared with cyclosporine microemulsion in primary simultaneous pancreas-kidney transplantation: 1-year results of a large multicenter trial.
Bechstein WO; Malaise J; Saudek F; Land W; Fernandez-Cruz L; Margreiter R; Nakache R; Secchi A; Vanrenterghem Y; Tydén G; Van Ophem D; Berney T; Boucek P; Landgraf R; Kahl A; Squifflet JP;
Transplantation; 2004 Apr; 77(8):1221-8. PubMed ID: 15114089
[TBL] [Abstract][Full Text] [Related]
70. Randomized comparison of triple therapy and antithymocyte globulin induction treatment after simultaneous pancreas-kidney transplantation.
Cantarovich D; Karam G; Giral-Classe M; Hourmant M; Dantal J; Blancho G; Le Normand L; Soulillou JP
Kidney Int; 1998 Oct; 54(4):1351-6. PubMed ID: 9767555
[TBL] [Abstract][Full Text] [Related]
71. Mycophenolate mofetil versus azathioprine for prevention of chronic allograft dysfunction in renal transplantation: the MYSS follow-up randomized, controlled clinical trial.
Remuzzi G; Cravedi P; Costantini M; Lesti M; Ganeva M; Gherardi G; Ene-Iordache B; Gotti E; Donati D; Salvadori M; Sandrini S; Segoloni G; Federico S; Rigotti P; Sparacino V; Ruggenenti P
J Am Soc Nephrol; 2007 Jun; 18(6):1973-85. PubMed ID: 17460145
[TBL] [Abstract][Full Text] [Related]
72. Randomized trial of mycophenolate mofetil versus enteric-coated mycophenolate sodium in primary renal transplantation with tacrolimus and steroid avoidance: four-year analysis.
Ciancio G; Gaynor JJ; Zarak A; Sageshima J; Guerra G; Roth D; Brown R; Kupin W; Chen L; Tueros L; Hanson L; Ruiz P; Burke GW
Transplantation; 2011 Jun; 91(11):1198-205. PubMed ID: 21107305
[TBL] [Abstract][Full Text] [Related]
73. Patterns of cytomegalovirus infection in simultaneous kidney-pancreas transplant recipients receiving tacrolimus, mycophenolate mofetil, and prednisone with ganciclovir prophylaxis.
Lo A; Stratta RJ; Egidi MF; Shokouh-Amiri MH; Grewal HP; Kisilisik AT; Trofe J; Alloway RR; Gaber LW; Gaber AO
Transpl Infect Dis; 2001 Mar; 3(1):8-15. PubMed ID: 11429034
[TBL] [Abstract][Full Text] [Related]
74. Anti-IL2 induction in liver transplantation with 93% rejection-free patient and graft survival at 18 months.
Ramirez CB; Doria C; di Francesco F; Iaria M; Kang Y; Marino IR
J Surg Res; 2007 Apr; 138(2):198-204. PubMed ID: 17292404
[TBL] [Abstract][Full Text] [Related]
75. Prednisone withdrawal 14 days after liver transplantation with mycophenolate: a prospective trial of cyclosporine and tacrolimus.
Stegall MD; Wachs ME; Everson G; Steinberg T; Bilir B; Shrestha R; Karrer F; Kam I
Transplantation; 1997 Dec; 64(12):1755-60. PubMed ID: 9422416
[TBL] [Abstract][Full Text] [Related]
76. Pancreas-after-kidney transplantation: an increasingly attractive alternative to simultaneous pancreas-kidney transplantation.
Larson TS; Bohorquez H; Rea DJ; Nyberg SL; Prieto M; Sterioff S; Textor SC; Schwab TR; Griffin MD; Gloor JM; Kudva YC; Kremers WK; Stegall MD
Transplantation; 2004 Mar; 77(6):838-43. PubMed ID: 15077023
[TBL] [Abstract][Full Text] [Related]
77. Randomized trial of tacrolimus + mycophenolate mofetil or azathioprine versus cyclosporine + mycophenolate mofetil after cadaveric kidney transplantation: results at three years.
Gonwa T; Johnson C; Ahsan N; Alfrey EJ; Halloran P; Stegall M; Hardy M; Metzger R; Shield C; Rocher L; Scandling J; Sorensen J; Mulloy L; Light J; Corwin C; Danovitch G; Wachs M; VanVeldhuisen P; Leonhardt M; Fitzsimmons WE
Transplantation; 2003 Jun; 75(12):2048-53. PubMed ID: 12829910
[TBL] [Abstract][Full Text] [Related]
78. Influence of tacrolimus plus mycophenolate mofetil regimens on acute rejection rate and diabetes mellitus development in renal transplant recipients.
Demirbaş A; Tuncer M; Yavuz A; Gürkan A; Kaçar S; Cetinkaya R; Tekin S; Akbaş SH; Akaydin M; Ersoy F; Yakupoğlu G
Transplant Proc; 2004; 36(1):175-7. PubMed ID: 15013338
[TBL] [Abstract][Full Text] [Related]
79. Reduced kidney transplant rejection rate and pharmacoeconomic advantage of mycophenolate mofetil.
Wüthrich RP; Weinreich T; Ambühl PM; Schwarzkopf AK; Candinas D; Binswanger U
Nephrol Dial Transplant; 1999 Feb; 14(2):394-9. PubMed ID: 10069195
[TBL] [Abstract][Full Text] [Related]
80. Efficacy and safety of tacrolimus compared with cyclosporin microemulsion in primary SPK transplantation: 3-year results of the Euro-SPK 001 trial.
Saudek F; Malaise J; Boucek P; Adamec M;
Nephrol Dial Transplant; 2005 May; 20 Suppl 2():ii3-10, ii62. PubMed ID: 15814547
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
